BDNF and early-onset autosomal dominant Alzheimer disease: Additionally, this approach may benefit other neurodegenerative conditions or neuropsychiatric disorders involving altered BDNF levels, such as Huntington’s disease, Alzheimer’s disease, and schizophrenia.